Brief: Skye Fund Iii Issued An Open Letter To Somalogic, Inc., Shareholders
20/12/2023 14:05
Dec 20 (Reuters) - Standard BioTools Inc LAB.O :
* SKYE FUND III: ISSUED AN OPEN LETTER TO SOMALOGIC, INC.,
SHAREHOLDERS
* SKYE FUND III: CO, TOGETHER WITH ITS AFFILIATES, OWNS
ABOUT 3.4
MILLION SHARES OF SOMALOGIC, INC.,
* SKYE FUND III SAYS IN LETTER TO SOMALOGIC SHAREHOLDERS
THAT
SOMALOGIC CAN THRIVE AS A STANDALONE ENTERPRISE
* SKYE FUND III: INTENTION TO VOTE AGAINST STANDARD
BIOTOOLS-SOMALOGIC MERGER AT UPCOMING SPECIAL MEETING OF
SHAREHOLDERS SCHEDULED FOR JAN 4, 2024
Source text for Eikon: ID:nGNX927R4Y
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders